Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Calgary, Alberta-based SemBioSys Genetics Inc. is a biotechnology company focused on the development, commercialization and production of biopharmaceuticals and non-pharmaceutical products based on its plant genetic engineering skills and proprietary oilbody-oleosin technology platform – the Stratosomeâ„¢ Biologics System. Its two lead pharmaceutical product candidates are insulin and a developmental cardiovascular drug called Apo AI. It also has a series of non-pharmaceutical products addressing animal and aquaculture health, nutritional oils and human topical markets. ( www.sembiosys.com )
SemBioSys Genetics Inc.
110 2985 – 23Rd Avenue N.E.
Calgary, Alberta T1Y 7L3
Canada
Tel: (403) 250-5424
Fax: (403) 250-3886